Review
Open access
Jul 2026
Long-read sequencing and next-generation CRISPR editors: a unified pipeline for rare disease precision medicine with ethical and regulatory perspectives
This review highlights recent progress in long-read sequencing and gene-editing technologies, discusses their complementary roles in rare disease research, and explores the translational opportunities and ethical challenges of combining these technologies to advance precision medicine.
Anshida Konamveettil Abdul Latheef, Mohammad Ali, O. Farahat et al.
· Frontiers in Medicine · 0 citations